Thought Leadership It’s Time to Shift the Conversation from Drug Price to Drug Value – Real-World Evidence Can Take Us There May 06, 2019
Thought Leadership Call to all Biopharma Employees: Tell Your State Rep to Protect Biotech Innovation Apr 22, 2019
Thought Leadership Re-Balance the Provider, Patient and Payer Triad to Forge More Equitable Medication Value Apr 10, 2019
Thought Leadership Why Massachusetts is the State of Possible – From the Speakers of MassBio’s Annual Meeting Mar 12, 2019
Thought Leadership Crossing the Chasm: Clinical to Commercial Scale-up of Gene Therapies Mar 08, 2019
